Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhubin Gahvari

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Current Treatment Options in Oncology|February 7, 2020
Dedifferentiated Liposarcoma: Systemic Therapy OptionsZhubin Gahvari, Amanda Parkes
Clinical Lymphoma, Myeloma & Leukemia|April 2, 2026
Autologous Hematopoietic Cell Transplantation (AHCT) for the Treatment of Newly Diagnosed Multiple MyelomaZhubin Gahvari, Natalie S Callander
Clinical Lymphoma, Myeloma & Leukemia|April 19, 2024
SOHO State of the Art Updates and Next Questions: Diagnosis and Management of Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple MyelomaTimothy Schmidt, Zhubin Gahvari, Natalie S Callander
European Journal of Haematology|December 15, 2023
Update on the current and future use of CAR-T to treat multiple myelomaZhubin Gahvari, Matthew Brunner, Timothy Schmidt, et al.
JCO Precision Oncology|June 7, 2024
Implementation of and Systems-Level Barriers to Guideline-Driven Germline Genetic Evaluation in the Care of Patients With Myelodysplastic Syndrome and Acute Myeloid LeukemiaLauren G Banaszak, Paloma L Cabral, Kelcy Smith-Simmer, et al.
American Journal of Hematology|September 25, 2020
Overall survival of patients with triple-class refractory multiple myeloma treated with selinexor plus dexamethasone vs standard of care in MAMMOTHRobert Cornell, Parameswaran Hari, Shijie Tang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 12, 2025
NCCN Guidelines® Insights: Myelodysplastic Syndromes, Version 2.2025Peter L Greenberg, Richard M Stone, Yasmin Abaza, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Current Treatment Options in Oncology|February 7, 2020
Dedifferentiated Liposarcoma: Systemic Therapy OptionsZhubin Gahvari, Amanda Parkes
Clinical Lymphoma, Myeloma & Leukemia|April 2, 2026
Autologous Hematopoietic Cell Transplantation (AHCT) for the Treatment of Newly Diagnosed Multiple MyelomaZhubin Gahvari, Natalie S Callander
Clinical Lymphoma, Myeloma & Leukemia|April 19, 2024
SOHO State of the Art Updates and Next Questions: Diagnosis and Management of Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple MyelomaTimothy Schmidt, Zhubin Gahvari, Natalie S Callander
European Journal of Haematology|December 15, 2023
Update on the current and future use of CAR-T to treat multiple myelomaZhubin Gahvari, Matthew Brunner, Timothy Schmidt, et al.
JCO Precision Oncology|June 7, 2024
Implementation of and Systems-Level Barriers to Guideline-Driven Germline Genetic Evaluation in the Care of Patients With Myelodysplastic Syndrome and Acute Myeloid LeukemiaLauren G Banaszak, Paloma L Cabral, Kelcy Smith-Simmer, et al.
American Journal of Hematology|September 25, 2020
Overall survival of patients with triple-class refractory multiple myeloma treated with selinexor plus dexamethasone vs standard of care in MAMMOTHRobert Cornell, Parameswaran Hari, Shijie Tang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 12, 2025
NCCN Guidelines® Insights: Myelodysplastic Syndromes, Version 2.2025Peter L Greenberg, Richard M Stone, Yasmin Abaza, et al.
Pageof 1